(Q71819946)

English

Development of new ricin A‐chain immunotoxins with potent anti‐tumor effects against human hodgkin cells in vitro and disseminated Hodgkin tumors in scid mice using high‐affinity monoclonal antibodies directed against the CD30 antigen

scientific article published on 01 October 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Development of new ricin A‐chain immunotoxins with potent anti‐tumor effects against human hodgkin cells in vitro and disseminated Hodgkin tumors in scid mice using high‐affinity monoclonal antibodies directed against the CD30 antigen (English)

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

monoclonal antibody

1 reference

based on heuristic

inferred from title

10

object named as

H. Lemke

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

author name string

R. Schnell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

C. Linnartz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

A. A. Katouzi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

G. Schön

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

H. Bohlen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

O. Horn-Lohrens

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

R. M. Parwaresch

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

H. Lange

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

V. Diehl

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591211

30 May 2024

language of work or name

0 references

publication date

1 October 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

9 October 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7591211

30 May 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910630216

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910630216

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

238-244

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

4

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Cocktails of ricin a‐chain immunotoxins against different antigens on hodgkin and sternberg‐reed cells have superior anti‐tumor effects against H‐RS cells in vitro and solid Hodgkin tumors in mice

6

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice

7

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

9

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immunohistological evidence

10

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

14

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

17

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Second solid malignancies after combined modality therapy for Hodgkin's disease

18

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

19

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins

20

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group

22

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

24

1 reference

10.1002/IJC.2910630216

https://api.crossref.org/works/10.1002/IJC.2910630216

30 May 2024

Identifiers

10.1002/IJC.2910630216

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591211%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71819946&oldid=2169430267"